ZNTL - Aset Bersih saben Siji Saham zentalis.com

The bps indicator demonstrates the net asset dynamics of Zentalis Pharmaceuticals (ZNTL), where the 1.99 level reflects the current value of the metric. Zentalis Pharmaceuticals develops targeted treatments for breast and ovarian tumors for oncology clinics. The development of a drug portfolio against solid neoplasms minimizes risks. Preclinical tests are being optimized through the implementation of AI-driven robotic bioscreening systems.

ZNTL (Zentalis Pharmaceuticals Inc) riwayat Aset Bersih saben Siji Saham saka 04.07.2022 nganti 30.10.2026

Rincian analitis lan laporan data perusahaan zentalis.com (ZNTL)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Zentalis Pharmaceuticals Inc|ZNTL - Rega prakiraan analis

- statistik kapitalisasi pasar:

Nilai pasar Zentalis Pharmaceuticals|ZNTL - Nilai Total Perusahaan

- data nilai buku modal saham:

Nilai Buku saben Saham Zentalis|ZNTL - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku zentalis.com|ZNTL - Nilai Agregat Aset

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal Zentalis Pharmaceuticals|ZNTL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Zentalis|ZNTL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Zentalis Pharmaceuticals|ZNTL - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Zentalis|Indikator likuiditas cepet zentalis.com

- indikator pendapatan resik lan kelipatan nilai:

ZNTL - Bathi pungkasan

Analisis kabeh metrik perusahaan:ZNTL - Zentalis Pharmaceuticals Inc

The efficacy of Zentalis Pharmaceuticals (ZNTL) cancer therapy depends directly on expensive cold chain infrastructure and reliable drug logistics. By analyzing the book value per share, an investor assesses the residual value of net assets divided by the number of shares, which allows for the determination of the company's actual capital net of liabilities and an evaluation of the level of investment protection.

Pesaing Zentalis Pharmaceuticals

OLMA: Nilai Akuntansi saben Saham|Puma Biotechnology - Rega Buku Saham|Greenwich LifeSciences (GLSI) - Aset Bersih saben Siji Saham|MGNX (macrogenics.com) - Aset Bersih saben Siji Saham|PSTV (Plus Therapeutics Inc) - Nilai Buku saben Saham|Aset Bersih saben Siji Saham PCSA|Aset Bersih saben Siji Saham Eagle Pharmaceuticals (EGRX)